Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult Participants
Clinical trial NCT06346509 · COMPLETED
Trial details
- NCT number
- NCT06346509
- Sponsor
- Portal Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-08
- Primary completion
- 2025-12-27
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.